[go: up one dir, main page]

HUP9904075A3 - Composition, for the treatment of asthma,containing loratadine and a decongestant - Google Patents

Composition, for the treatment of asthma,containing loratadine and a decongestant

Info

Publication number
HUP9904075A3
HUP9904075A3 HU9904075A HUP9904075A HUP9904075A3 HU P9904075 A3 HUP9904075 A3 HU P9904075A3 HU 9904075 A HU9904075 A HU 9904075A HU P9904075 A HUP9904075 A HU P9904075A HU P9904075 A3 HUP9904075 A3 HU P9904075A3
Authority
HU
Hungary
Prior art keywords
decongestant
asthma
treatment
composition
containing loratadine
Prior art date
Application number
HU9904075A
Other languages
Hungarian (hu)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HUP9904075A2 publication Critical patent/HUP9904075A2/en
Publication of HUP9904075A3 publication Critical patent/HUP9904075A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU9904075A 1996-10-31 1997-10-29 Composition, for the treatment of asthma,containing loratadine and a decongestant HUP9904075A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31

Publications (2)

Publication Number Publication Date
HUP9904075A2 HUP9904075A2 (en) 2000-05-28
HUP9904075A3 true HUP9904075A3 (en) 2002-02-28

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904075A HUP9904075A3 (en) 1996-10-31 1997-10-29 Composition, for the treatment of asthma,containing loratadine and a decongestant

Country Status (21)

Country Link
EP (1) EP0941091A1 (en)
JP (1) JP2000505104A (en)
KR (1) KR20000052922A (en)
CN (1) CN1235545A (en)
AR (1) AR008908A1 (en)
AU (1) AU731756B2 (en)
BR (1) BR9712705A (en)
CA (1) CA2268546A1 (en)
CO (1) CO4910128A1 (en)
CZ (1) CZ150999A3 (en)
HU (1) HUP9904075A3 (en)
ID (1) ID23431A (en)
IL (1) IL129662A0 (en)
NO (1) NO992062D0 (en)
NZ (1) NZ335078A (en)
PE (1) PE11399A1 (en)
PL (1) PL333056A1 (en)
SK (1) SK54599A3 (en)
TR (1) TR199901003T2 (en)
WO (1) WO1998018470A1 (en)
ZA (1) ZA979731B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1205799A (en) * 1997-10-29 1999-05-17 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (en) * 1998-07-28 2001-02-23 Nicox Sa SALTS OF NITRIC ACID WITH ACTIVE DRUGS IN THE TREATMENT OF DISEASES OF THE RESPIRATORY SYSTEM
PE20001070A1 (en) * 1998-09-10 2000-10-19 Schering Corp METHODS AND COMPOSITIONS TO TREAT SINUSITIS, OTITIS MEDIA AND OTHER RELATED DISORDERS USING ANTIHISTAMINES
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
KR100505899B1 (en) * 1999-02-23 2005-08-01 주식회사유한양행 Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
EP1154762B1 (en) * 1999-02-23 2003-11-05 Yuhan Corporation Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
WO2000057880A1 (en) * 1999-03-29 2000-10-05 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
WO2001045668A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
AU2276801A (en) * 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
WO2001078782A1 (en) * 2000-04-14 2001-10-25 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
BR0111018A (en) * 2000-05-25 2004-02-17 Schering Corp Liquid and solid stable formulations
MXPA03011705A (en) * 2001-06-20 2004-03-19 Schering Corp Antihistamines for the treatment of nasal congestion and nasal obstruction.
RU2423979C2 (en) * 2005-06-17 2011-07-20 АФТ Фармасьютикалз Лимитед Novel pharmaceutic composition and its application in method of treatment of patients with hyperaemia and edema of mucous membrane of upper airways
NZ588134A (en) 2005-06-17 2010-11-26 Aft Pharmaceuticals Ltd Novel pharmaceutical for use in a method for treatment of upper respiratory mucosal congestion
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
NZ573173A (en) * 2006-06-01 2012-03-30 Msd Consumer Care Inc Phenylephrine pharmaceutical formulation and compositions for colonic absorption
KR101540191B1 (en) * 2014-02-24 2015-07-28 성균관대학교산학협력단 Composition comprising Loratadine for anti-inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
HUP9904075A2 (en) 2000-05-28
SK54599A3 (en) 2000-08-14
NO992062L (en) 1999-04-29
AU731756B2 (en) 2001-04-05
CN1235545A (en) 1999-11-17
EP0941091A1 (en) 1999-09-15
NZ335078A (en) 2000-10-27
NO992062D0 (en) 1999-04-29
JP2000505104A (en) 2000-04-25
CA2268546A1 (en) 1998-05-07
BR9712705A (en) 1999-10-26
PE11399A1 (en) 1999-02-09
PL333056A1 (en) 1999-11-08
CZ150999A3 (en) 1999-10-13
ID23431A (en) 2000-04-20
AU4995397A (en) 1998-05-22
KR20000052922A (en) 2000-08-25
TR199901003T2 (en) 1999-07-21
CO4910128A1 (en) 2000-04-24
IL129662A0 (en) 2000-02-29
WO1998018470A1 (en) 1998-05-07
ZA979731B (en) 1998-04-29
AR008908A1 (en) 2000-02-23

Similar Documents

Publication Publication Date Title
NZ294392A (en) Asthma drugs and compounds
AU133903S (en) Inhaler device
HUP9904075A3 (en) Composition, for the treatment of asthma,containing loratadine and a decongestant
HRP960365B1 (en) New medicaments and the use thereof
GB9606805D0 (en) Medicaments
AU125455S (en) Corkscrew
GB9611947D0 (en) Medicaments
ZA981163B (en) Gas treatment devices
IL130348A0 (en) Imidazopyridazines and medicaments containing the same
PL322596A1 (en) Antiglucocorticoid drug
GB9605293D0 (en) Medicaments
GB2294646B (en) Material treatment
GB2355006B (en) Materials treatment
GB9415901D0 (en) Novel compounds and treatment
GB9606721D0 (en) Infusion packages and methods for their manufacture
HUP0103569A2 (en) New medicament and process for its preparation
HK1018941A (en) Composition, for the treatment of asthma, containing loratadine and a decongestant
GB9415900D0 (en) Novel compounds and treatment
GB9611167D0 (en) Medicaments
IL125286A0 (en) Phenanthridine compounds medicaments containing the same and use thereof
HUP0003908A3 (en) Use of substituted azaspirane in the manufacture of a medicament for use in treating asthma
GB9423356D0 (en) Oral treatment
GB9613096D0 (en) Medicaments
GB9727276D0 (en) Improvements in medicaments for asthma treatment
GB9825972D0 (en) Improvements in medicaments for asthma treatment